Beth Hecht
CIK 1652410 · See Remarks · last filed 2026-08-04
Beth Hecht is a corporate insider who has filed 48 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing shows the insider sold $133.6K of XERS on Aug 4, 2026. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$9.65M
4
48
-$1.33M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XERS | See Remarks | 1,144,462 | $8.43 | $9.65M | -$1.33M | 29 | 2026-08-04 |
| Iterum Therapeutics plc (ITRM) Delisted | Director | 18,839 | $0.03 | $565 | $0 | 6 | 2023-06-15 |
| AYTU | Director | 453 | $2.25 | $1.0K | $0 | 1 | 2021-04-12 |
| Neos Therapeutics, Inc. (NEOS) Delisted | Director | 0 | $1.15 | $0 | $0 | 7 | 2021-03-19 |
Recent Filings
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-04 | XERS | Sell (S) | −16,666 | -$133.6K | EDGAR |
| 2026-07-02 | XERS | Sell (S) | −16,666 | -$133.9K | EDGAR |
| 2026-07-01 | XERS | Notice (144) | −49,998 | -$396.0K | EDGAR |
| 2026-06-02 | XERS | Sell (S) | −16,667 | -$101.0K | EDGAR |
| 2026-05-01 | XERS | Sell (S) | −16,667 | -$103.8K | EDGAR |
| 2026-04-03 | XERS | Sell (S) | −16,667 | -$99.9K | EDGAR |
| 2026-03-04 | XERS | Sell (S) | −16,667 | -$104.1K | EDGAR |
| 2026-03-02 | XERS | Notice (144) | −66,668 | -$408.0K | EDGAR |
| 2026-02-02 | XERS | Mixed | −64,929 | -$1.37M | EDGAR |
| 2026-01-05 | XERS | Sell (S) | −16,667 | -$123.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.